Osteron Tablet (Risedronate Sodium)

Adult dose

1. Adults : Administer 35 mg of risedronate sodium orally once weekly. 2. Elderly patients : No dosage adjustment is necessary in elderly patients (over 60 years of age), as the bioavailability and pharmacodynamics of this drug are similar to those in younger people. 4. Patients with renal impairment : No dosage adjustment is necessary in patients with a creatinine clearance of 30 mL/min or greater. This drug is contraindicated in patients with severe renal impairment and a creatinine clearance of less than 30 mL/min. ○ Because food interferes with the absorption of this drug, take it at least 30 minutes before breakfast for adequate absorption, or at least 2 hours before or after consuming any food or beverages at any time of day. To facilitate passage of this drug into the stomach and reduce the possibility of esophageal irritation, take it with an adequate amount of plain water (170 ∼ 230 mL) while in an upright position. Taking this drug with other beverages, including mineral water, may reduce its absorption. Do not chew or suck this drug because of the possibility of oropharyngeal ulceration. Patients should not lie down for at least 30 minutes after taking it. ○ If a patient forgets to take this drug on the scheduled day, take it the next morning when remembered. Resume the next dose on the originally scheduled day. Do not take 2 tablets on the same day.

Child dose

3. Children : The safety and efficacy of this drug in children under 18 years of age have not been established.

This medication can irritate the stomach and esophagus, thus patients with esophageal disorders, gastric inflammation, ulcers, etc., should take caution. It should be taken with a sufficient amount of water, and it is advised not to lie down for at least 30 minutes after taking it. If symptoms such as pain in the esophagus or difficulty swallowing occur, stop taking the medication immediately and consult a physician. This medication is contraindicated in patients with specific esophageal diseases, hypocalcemia, severe renal impairment, women who are pregnant or may become pregnant, and nursing mothers. Patients with genetic issues such as lactose intolerance should also not take this medication. As a bisphosphonate, there is a rare risk of serious side effects such as jaw necrosis, so it is important to maintain oral health and consult a professional if dental treatment is necessary. Adequate intake of calcium and vitamin D is important, and the timing and method of taking the medication should be strictly followed as it may affect absorption when taken with other medications or foods. This medication has not been proven safe and effective for children, and elderly patients can use it without special differences. In case of overdose, symptoms of hypocalcemia may occur, and immediate contact with a healthcare facility for appropriate treatment is necessary. Lastly, this medication should be stored out of reach of children and not transferred to other containers for safety.

• Esophagitis
• esophageal ulcer
• esophageal erosion
• esophageal obstruction
• esophageal perforation
• bleeding
• gastric ulcer
• duodenal ulcer
• infection
• low back pain

This medication should be stored in a tightly sealed container to prevent moisture and air from entering. It is best to maintain a storage temperature between 1°C and 30°C.

Appearance

Pale orange, oval film-coated tablet

Package unit

4 tablets/PTP